Cargando…
Polyarthritis and Psoriasiform Skin Lesions following Pembrolizumab Therapy
A notable feature of immune checkpoint inhibitor (ICI) therapy in oncology patients is its association with increased frequency of immune related adverse reactions, directly associated with their unique mechanism of action. These adverse events are of great interest to rheumatologists, as not only d...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Mediterranean Journal of Rheumatology (MJR)
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8802194/ https://www.ncbi.nlm.nih.gov/pubmed/35128331 http://dx.doi.org/10.31138/mjr.32.4.367 |